查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1869674

人體組成監測儀市場規模、佔有率和趨勢分析報告：按產品、最終用途、地區和細分市場預測（2025-2033 年）

Body Composition Analyzers Market Size, Share & Trends Analysis Report By Product, By End-use By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

人體成分監測儀市場摘要

2024年全球人體組成監測儀市場規模估計為7.142億美元，預計2033年將達到12.616億美元。

預計從 2025 年到 2033 年，該行業將以 6.4% 的複合年成長率成長。這一成長是由人們對肥胖和慢性疾病的認知不斷提高、健身和健康趨勢的日益成長以及預防性護理的普及所推動的。

包括攜帶式和易用型設備在內的技術進步進一步推動了市場需求。此外，對運動科學、職場健康計畫和醫療保健基礎設施的投資不斷增加，也為市場擴張提供了支持。

由於肥胖率上升、代謝性疾病盛行率增加以及消費者健康意識增強，全球人體組成分析儀產業正經歷快速成長。預計到2030年，全球將有11.3億成年人患有肥胖症，到2024年，將有5.06億人患有代謝性疾病。傳統的BMI等指標往往無法檢測出肌肉少症性肥胖，這種肥胖症的特徵是高脂肪和低肌肉量並存。因此，臨床指南擴大推薦基於電阻活體組織切片的人體組成分析，因為該方法可以更準確地評估脂肪量、肌肉量、內臟脂肪量和水分含量。這種轉變使分析儀從可有可無的工具轉變為預防和臨床護理中必不可少的設備，使其成為醫療診斷市場的核心組成部分。

醫療系統和保險公司正在進一步推動市場擴張。支付方正在推出獎勵，鼓勵早期代謝檢測，因為早期風險分層有助於降低長期治療成本。醫院和診所正在將體成分監測儀納入年度健康篩檢計畫、減重手術治療流程和營養不良篩檢通訊協定。例如，2025 年美國醫師收費標準將涵蓋使用電阻影像技術進行肌肉量評估的費用，歐洲的支付方也在回應全球營養不良領導力舉措，擴大肌肉減少症診斷的覆蓋範圍。這些政策降低了小規模診所和基層醫療機構採用該技術的門檻，從而將市場擴展到大型醫院之外。企業健康計畫也越來越補貼內部掃描費用，進一步擴大了參保用戶群體。在亞太地區，由於試驗研究表明該技術有助於降低糖尿病和心血管疾病相關支出，預計該地區將更廣泛地採用該技術，這表明該地區未來具有成長潛力。

政府主導也正在推動人體組成分析儀的普及應用。例如，位於新德里的全印度醫學科學研究所（AIIMS）於2024年初透過政府電子市場（GeM）購買了一台人體組成分析儀，顯示政府致力於向公共醫療機構引進先進的診斷設備。

主導需求同樣重要。人們對維持精瘦體脂肪和健康老齡化的意識日益增強，導致社群媒體上「瘦胖」現象的興起。健身愛好者、運動員和健身房會員不再只關注體重，而是更重視追蹤體脂率、水分含量和內臟脂肪。零售商報告稱，智慧體重計的銷量實現了兩位數的成長，而健康應用程式則將電阻測量與飲食和運動計劃相結合。 Hume Health Body Pod 等設備（於 2025 年 9 月發布）正是這一趨勢的體現。 Body Pod 採用多頻生物電電阻分析技術，可提供 40 多項健康指標，包括體脂率、骨骼肌品質、體總水分、內臟脂肪指數和基礎代謝率。分段分析功能可以追蹤特定身體部位（例如手臂、腿部和軀幹）的數據，從而為訓練、恢復和長期健康趨勢提供切實可行的建議。其居家使用、非侵入式的設計使其易於使用，彌合了消費者市場和臨床市場之間的差距。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章：體組成監測儀市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 人體成分分析儀市場分析工具
    • 產業分析—波特五力分析
    • PESTEL 分析

第4章 人體組成監測儀市場：依產品分類的估算與趨勢分析

  • 細分儀表板
  • 產品變異分析
  • 人體組成監測儀市場規模及趨勢分析（依產品分類），2021-2033年
  • 卡尺
  • 電阻分析儀
  • 靜壓計量
  • 雙能量X光檢測法（DEXA）
  • 空氣血管脈動血流量記錄
  • 其他

第5章：體成分監測儀市場：依最終用途分類的估算與趨勢分析

  • 細分儀表板
  • 依最終用途進行變異分析
  • 2021-2033年依最終用途分類的人體組成監測儀市場規模及趨勢分析
  • 醫院和診所
  • 健身中心/健身房
  • 居家護理中心

第6章 人體組成監測儀市場：區域估算與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 區域概況
  • 市場規模、預測趨勢分析（2021-2033年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭情勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 主要企業市佔率分析，2025 年
  • Company Position Analysis
  • 公司分類（新興企業、創新者、領導者）
  • 公司簡介
    • Hologic Inc.
    • Bodystat Ltd
    • COSMED Srl
    • Charder Electronic Co. Ltd
    • InBody Co. Ltd
    • GE Healthcare
    • Tanita Corporation
    • Omron Corporation
    • Seca GmbH
    • Maltron International
Product Code: GVR-4-68040-760-5

Body Composition Analyzers Market Summary

The global body composition analyzers market size was estimated at USD 714.2 million in 2024 and is projected to reach USD 1,261.6 million by 2033, growing at a CAGR of 6.4% from 2025 to 2033. This growth is driven by rising awareness of obesity and chronic diseases, increasing fitness and wellness trends, and growing adoption of preventive healthcare.

Technological advancements, including portable and user-friendly devices, further fuel demand. In addition, rising investments in sports science, workplace wellness programs, and healthcare infrastructure support market expansion.

The global body composition analyzers industry is experiencing rapid growth, driven by rising obesity rates, increasing metabolic disorders, and heightened consumer health awareness. Obesity is projected to affect 1.13 billion adults by 2030, while in 2024, 506 million people are reported to have metabolic disorders. Traditional metrics like BMI often fail to detect sarcopenic obesity, where high fat and low muscle mass coexist. As a result, clinical guidelines increasingly favor impedance-based body composition analysis, which offers a more precise assessment of fat, muscle, visceral adiposity, and hydration levels. This shift is transforming analyzers from optional tools into essential devices in both preventative and clinical care, making them a core segment of the healthcare diagnostic market.

Healthcare systems and insurers are further fueling market expansion. Payer incentives now reward early risk stratification, as detecting metabolic deterioration early reduces long-term treatment costs. Hospitals and clinics are incorporating body composition analyzers into annual wellness programs, bariatric surgery pathways, and malnutrition screening protocols. For example, the 2025 U.S. Physician Fee Schedule reimburses impedance-based muscle-mass assessments, while European payers increasingly cover sarcopenia diagnostics following the Global Leadership Initiative on Malnutrition. This policy develops lower barriers for small clinics and primary care offices, expanding the market beyond large hospitals. Corporate wellness programs also subsidize onsite scans, further enlarging the reimbursed user base. In Asia Pacific, broader adoption is expected as pilot studies demonstrate reductions in diabetes- and cardiovascular-related expenditures, indicating future regional growth potential.

Government initiatives further bolster the adoption of body composition analyzers. For instance, the All-India Institute of Medical Sciences (AIIMS) in New Delhi procured a body composition analyzer through the Government e-Marketplace (GeM) in early 2024, indicating the government's commitment to integrating advanced diagnostic tools in public healthcare institutions

Consumer-driven demand is equally significant. Awareness of lean mass preservation and healthy aging has risen, with social media highlighting the "skinny-fat" phenomenon. Fitness enthusiasts, athletes, and gym members now prioritize tracking fat percentage, hydration, and visceral fat over simple weight. Retailers report double-digit growth in connected scales, while health apps integrate impedance results with diet and exercise plans. Devices like the Hume Health Body Pod, launched in September 2025, exemplify this trend. Using multi-frequency bioelectrical impedance analysis, the Body Pod provides over 40 health metrics, including body fat, skeletal muscle, total body water, visceral fat index, and basal metabolic rate. Segmental analysis allows users to track specific regions, arms, legs, and trunks, offering actionable insights for training, recovery, and long-term health trends. Its home-based, non-invasive design makes it accessible, bridging the consumer and clinical segments of the market.

Global Body Composition Analyzers Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global body composition analyzers market report based on product, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Calipers
  • Bioimpedance Analyzers
  • Hydrostatic Weighing
  • DEXA (Dual-Energy X-Ray Absorptiometry)
  • Air-Displacement Plethysmography
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Fitness Centers and Gymnasiums
  • Homecare Center
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Body Composition Analyzers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Body Composition Analyzers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Body Composition Analyzers Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Body Composition Analyzers Product Market Movement Analysis
  • 4.3. Global Body Composition Analyzers Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Calipers
    • 4.4.1. Calipers market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Bioimpedance Analyzers
    • 4.5.1. Bioimpedance analyzers market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Hydrostatic Weighing
    • 4.6.1. Hydrostatic Weighing market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.7. DEXA (Dual-Energy X-Ray Absorptiometry)
    • 4.7.1. DEXA (Dual-Energy X-Ray Absorptiometry) market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.8. Air-Displacement Plethysmography
    • 4.8.1. Air-Displacement Plethysmography market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Body Composition Analyzers Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Body Composition Analyzers End Use Market Movement Analysis
  • 5.3. Global Body Composition Analyzers Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 5.4. Hospitals & Clinics
    • 5.4.1. Hospitals & Clinics market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Fitness Centers and Gymnasiums
    • 5.5.1. Fitness Centers and Gymnasiums market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Homecare Center
    • 5.6.1. Homecare Center market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Body Composition Analyzers Market: Regional Estimates & Trend Analysis By Product, End Use

  • 6.1. Regional Market Share Analysis, 2025 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. Reimbursement structure
      • 6.5.1.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement structure
      • 6.5.2.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement structure
      • 6.5.3.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Reimbursement structure
      • 6.6.1.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement structure
      • 6.6.2.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement structure
      • 6.6.3.5. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Competitive scenario
      • 6.6.4.3. Regulatory framework
      • 6.6.4.4. Reimbursement structure
      • 6.6.4.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Competitive scenario
      • 6.6.5.3. Regulatory framework
      • 6.6.5.4. Reimbursement structure
      • 6.6.5.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Competitive scenario
      • 6.6.6.3. Regulatory framework
      • 6.6.6.4. Reimbursement structure
      • 6.6.6.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Competitive scenario
      • 6.6.7.3. Regulatory framework
      • 6.6.7.4. Reimbursement structure
      • 6.6.7.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Competitive scenario
      • 6.6.8.3. Regulatory framework
      • 6.6.8.4. Reimbursement structure
      • 6.6.8.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement structure
      • 6.7.1.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement structure
      • 6.7.2.5. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement structure
      • 6.7.3.5. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement structure
      • 6.7.4.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement structure
      • 6.7.5.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement structure
      • 6.7.6.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement structure
      • 6.8.1.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement structure
      • 6.8.2.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement structure
      • 6.9.1.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement structure
      • 6.9.2.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement structure
      • 6.9.3.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Competitive scenario
      • 6.9.4.3. Regulatory framework
      • 6.9.4.4. Reimbursement structure
      • 6.9.4.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share analysis, 2025
  • 7.4. Company Position Analysis
  • 7.5. Company Categorization (Emerging Players, Innovators and Leaders)
  • 7.6. Company Profiles
    • 7.6.1. Hologic Inc.
      • 7.6.1.1. Company overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Product benchmarking
      • 7.6.1.4. Strategic initiatives
    • 7.6.2. Bodystat Ltd
      • 7.6.2.1. Company overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Strategic initiatives
    • 7.6.3. COSMED Srl
      • 7.6.3.1. Company overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Strategic initiatives
    • 7.6.4. Charder Electronic Co. Ltd
      • 7.6.4.1. Company overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Strategic initiatives
    • 7.6.5. InBody Co. Ltd
      • 7.6.5.1. Company overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Strategic initiatives
    • 7.6.6. GE Healthcare
      • 7.6.6.1. Company overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Strategic initiatives
    • 7.6.7. Tanita Corporation
      • 7.6.7.1. Company overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Product benchmarking
      • 7.6.7.4. Strategic initiatives
    • 7.6.8. Omron Corporation
      • 7.6.8.1. Company overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Product benchmarking
      • 7.6.8.4. Strategic initiatives
    • 7.6.9. Seca GmbH
      • 7.6.9.1. Company overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Product benchmarking
      • 7.6.9.4. Strategic initiatives
    • 7.6.10. Maltron International
      • 7.6.10.1. Company overview
      • 7.6.10.2. Financial performance
      • 7.6.10.3. Product benchmarking
      • 7.6.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America body composition analyzers market, By country, 2021 - 2033 (USD Million)
  • Table 3 North America body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 4 North America body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 5 U.S. body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 6 U.S. body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 7 Canada body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 8 Canada body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 9 Mexico body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 10 Mexico body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 11 Europe body composition analyzers market, By country, 2021 - 2033 (USD Million)
  • Table 12 Europe body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 13 Europe body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 14 UK body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 15 UK body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 16 Germany body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 17 Germany body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 18 France body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 19 France body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 20 Italy body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 21 Italy body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 22 Denmark body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 23 Denmark body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 24 Sweden body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 25 Sweden body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 26 Norway body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 27 Norway body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 28 Asia Pacific body composition analyzers market, By country, 2021 - 2033 (USD Million)
  • Table 29 Asia Pacific body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 31 Japan body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 32 Japan body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 33 China body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 34 China body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 35 India body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 36 India body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 37 Australia body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 38 Australia body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 39 South Korea body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 40 South Korea body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 41 Thailand body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 42 Thailand body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 43 Latin America body composition analyzers market, By Country, 2021 - 2033 (USD Million)
  • Table 44 Latin America body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 45 Latin America body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 46 Brazil body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 47 Brazil body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 48 Argentina body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 49 Argentina body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 50 Middle East & Africa body composition analyzers market, By country, 2021 - 2033 (USD Million)
  • Table 51 Middle East & Africa body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 52 Middle East & Africa body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 53 South Africa body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 54 South Africa body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 55 Saudi Arabia body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 56 Saudi Arabia body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 57 UAE body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 58 UAE body composition analyzers market, By end use, 2021 - 2033 (USD Million)
  • Table 59 Kuwait body composition analyzers market, By product, 2021 - 2033 (USD Million)
  • Table 60 Kuwait body composition analyzers market, By end use, 2021 - 2033 (USD Million)

List of Figure

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Body composition analyzers market: Market outlook
  • Fig. 14 Body composition analyzers market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Body composition analyzers market driver impact
  • Fig. 20 Body composition analyzers restraint impact
  • Fig. 21 Body composition analyzers market: product movement analysis
  • Fig. 22 Body composition analyzers market: product outlook and key takeaways
  • Fig. 23 Calipers market estimates and forecast, 2021 - 2033
  • Fig. 24 Bioimpedance Analyzers market estimates and forecast, 2021 - 2033
  • Fig. 25 Hydrostatic Weighing market estimates and forecast, 2021 - 2033
  • Fig. 26 DEXA (Dual-Energy X-Ray Absorptiometry) market estimates and forecast, 2021 - 2033
  • Fig. 27 Air-Displacement Plethysmography market estimates and forecasts, 2021 - 2033
  • Fig. 28 Others market estimates and forecast, 2021 - 2033
  • Fig. 29 Body composition analyzers market: end use movement analysis
  • Fig. 30 Body composition analyzers market: end use outlook and key takeaways
  • Fig. 31 Hospitals & Clinics market estimates and forecast, 2021 - 2033
  • Fig. 32 Fitness Centers and Gymnasiums market estimates and forecast, 2021 - 2033
  • Fig. 33 Homecare Center market estimates and forecast, 2018-2033
  • Fig. 34 Global Body Composition Analyzers Market: regional movement analysis
  • Fig. 35 Global Body Composition Analyzers Market: regional outlook and key takeaways
  • Fig. 36 North America
  • Fig. 37 North America market estimates and forecast, 2021 - 2033
  • Fig. 38 U.S.
  • Fig. 39 U.S. market estimates and forecast, 2021 - 2033
  • Fig. 40 Canada
  • Fig. 41 Canada market estimates and forecast, 2021 - 2033
  • Fig. 42 Mexico
  • Fig. 43 Mexico market estimates and forecast, 2021 - 2033
  • Fig. 44 Europe
  • Fig. 45 Europe. market estimates and forecast, 2021 - 2033
  • Fig. 46 UK
  • Fig. 47 UK market estimates and forecast, 2021 - 2033
  • Fig. 48 Germany
  • Fig. 49 Germany market estimates and forecast, 2021 - 2033
  • Fig. 50 France
  • Fig. 51 France market estimates and forecast, 2021 - 2033
  • Fig. 52 Italy
  • Fig. 53 Italy market estimates and forecast, 2021 - 2033
  • Fig. 54 Spain
  • Fig. 55 Spain market estimates and forecast, 2021 - 2033
  • Fig. 56 Denmark
  • Fig. 57 Denmark market estimates and forecast, 2021 - 2033
  • Fig. 58 Sweden
  • Fig. 59 Sweden market estimates and forecast, 2021 - 2033
  • Fig. 60 Norway
  • Fig. 61 Norway market estimates and forecast, 2021 - 2033
  • Fig. 62 Asia Pacific
  • Fig. 63 Asia Pacific market estimates and forecast, 2021 - 2033
  • Fig. 64 Japan
  • Fig. 65 Japan market estimates and forecast, 2021 - 2033
  • Fig. 66 China
  • Fig. 67 China market estimates and forecast, 2021 - 2033
  • Fig. 68 India
  • Fig. 69 India market estimates and forecast, 2021 - 2033
  • Fig. 70 South Korea
  • Fig. 71 South Korea market estimates and forecast, 2021 - 2033
  • Fig. 72 Thailand
  • Fig. 73 Thailand market estimates and forecast, 2021 - 2033
  • Fig. 74 Australia
  • Fig. 75 Australia market estimates and forecast, 2021 - 2033
  • Fig. 76 Latin America
  • Fig. 77 Latin America market estimates and forecast, 2021 - 2033
  • Fig. 78 Brazil
  • Fig. 79 Brazil market estimates and forecast, 2021 - 2033
  • Fig. 80 Argentina
  • Fig. 81 Argentina market estimates and forecast, 2021 - 2033
  • Fig. 82 Middle East and Africa
  • Fig. 83 Middle East and Africa. market estimates and forecasts, 2021 - 2033
  • Fig. 84 Saudi Arabia
  • Fig. 85 Saudi Arabia market estimates and forecast, 2021 - 2033
  • Fig. 86 South Africa
  • Fig. 87 South Africa market estimates and forecast, 2021 - 2033
  • Fig. 88 UAE
  • Fig. 89 UAE market estimates and forecast, 2021 - 2033
  • Fig. 90 Kuwait
  • Fig. 91 Kuwait market estimates and forecast, 2021 - 2033
  • Fig. 92 Participant categorization- Body composition analyzers market
  • Fig. 93 Market share of key market players- Body composition analyzers market